# NIH Reporter #5R50CA293837-04

Investigating epigenetic mechanisms of cancer

**Recipient:** VAN ANDEL RESEARCH INSTITUTE

**Award Amount:** $204,106.00
**Ceiling:** $204,106.00

**Awarded:** September 17, 2026

**Identifier:** 5R50CA293837-04

Research grant awarded by the National Cancer Institute to VAN ANDEL RESEARCH INSTITUTE for studying epigenetic mechanisms of cancer, funded at $204,106 for the period 2024-2029.

### Description

This is a research grant award from the National Cancer Institute for investigating epigenetic mechanisms of cancer, with a focus on histone mutations, chromatin dynamics, and therapy resistance. The project involves multiple techniques including biochemical assays, gene expression analysis, chromatin profiling, and CRISPR screens. The award supports a project period from September 2024 to August 2029, with a total funding of $204,106 for fiscal year 2026.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11401400)